JP2008509222A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509222A5
JP2008509222A5 JP2007525700A JP2007525700A JP2008509222A5 JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5 JP 2007525700 A JP2007525700 A JP 2007525700A JP 2007525700 A JP2007525700 A JP 2007525700A JP 2008509222 A5 JP2008509222 A5 JP 2008509222A5
Authority
JP
Japan
Prior art keywords
methyloxy
naphthyridin
dihydro
oxo
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525700A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028107 external-priority patent/WO2006020561A2/en
Publication of JP2008509222A publication Critical patent/JP2008509222A/ja
Publication of JP2008509222A5 publication Critical patent/JP2008509222A5/ja
Pending legal-status Critical Current

Links

JP2007525700A 2004-08-09 2005-08-09 抗菌剤 Pending JP2008509222A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59993104P 2004-08-09 2004-08-09
PCT/US2005/028107 WO2006020561A2 (en) 2004-08-09 2005-08-09 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008509222A JP2008509222A (ja) 2008-03-27
JP2008509222A5 true JP2008509222A5 (cg-RX-API-DMAC7.html) 2008-09-25

Family

ID=35908073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525700A Pending JP2008509222A (ja) 2004-08-09 2005-08-09 抗菌剤

Country Status (4)

Country Link
US (1) US20070161627A1 (cg-RX-API-DMAC7.html)
EP (1) EP1784410A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008509222A (cg-RX-API-DMAC7.html)
WO (1) WO2006020561A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017468A2 (en) * 2004-08-02 2006-02-16 Glaxo Group Limited Antibacterial agents
US7648980B2 (en) * 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) * 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
KR101567096B1 (ko) * 2007-04-20 2015-11-06 글락소 그룹 리미티드 항균제로서의 트리시클릭 질소 함유 화합물
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
BR112017003705B1 (pt) 2014-08-22 2022-07-12 Glaxosmithkline Intellectual Property Development Limited Compostos contendo nitrogênio tricíclicos para o tratamento de infecção por neisseria gonorrhoea
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2020169593A1 (en) 2019-02-19 2020-08-27 Univerza V Ljubljani Antibacterials based on monocyclic fragments coupled to aminopiperidine naphthyridine scaffold

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602864B1 (en) * 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
SK71299A3 (en) * 1996-12-13 2000-12-11 Rhone Poulenc Rorer Pharma Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
GB9824612D0 (en) * 1998-11-10 1999-01-06 Glynwed Metal Processing Limit A blind fastening device
CN1452619A (zh) * 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
ATE463494T1 (de) * 2002-10-10 2010-04-15 Morphochem Ag Komb Chemie Neue verbindungen mit antibakterieller aktivität
TW200427688A (en) * 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
GB0412467D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
JP2008509222A5 (cg-RX-API-DMAC7.html)
JP7297053B2 (ja) 神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解
JP2008506695A5 (cg-RX-API-DMAC7.html)
JP2008507543A5 (cg-RX-API-DMAC7.html)
JP2009532504A5 (cg-RX-API-DMAC7.html)
JP2008505920A5 (cg-RX-API-DMAC7.html)
JP4654035B2 (ja) 抗菌剤
JP2005525324A5 (cg-RX-API-DMAC7.html)
JP2008502689A5 (cg-RX-API-DMAC7.html)
EP3302482A1 (en) Tank-binding kinase-1 protacs and associated methods of use
AR041672A1 (es) Compuesto biciclico de benzamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimiento para prepararlo
JP2005504080A5 (cg-RX-API-DMAC7.html)
ES2190570T3 (es) Compuestos heterociclicos de piperazinilo para el tratamiento de la demencia.
JP4704755B2 (ja) 抗菌剤
SE0402735D0 (sv) Novel compounds
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
JP2007516194A5 (cg-RX-API-DMAC7.html)
JP2008505926A5 (cg-RX-API-DMAC7.html)
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
RU2000105266A (ru) Производные 1-(n-фениламиноалкил)-пиперазина, замещенные в положении 2 фенильного кольца
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
DE60208178D1 (de) Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten
JP2008508359A5 (cg-RX-API-DMAC7.html)